Clinical Trials on Various Disorders

Clinical Trials on various diseases include Clinical Trials in long chronic diseases like AIDS, Benign and Malignant Tumours, Cardiovascular diseases, Diabetes, Clinical Trials on Monoclonal and Polyclonal Antibodies, Neurological, Physiological and Psychological Disorders.

Market Analysyis : The global clinical trials market size was valued at USD 40.0 billion in 2016 and is expected to grow at a CAGR of 5.7% over the forecast period. Key drivers impacting the market growth are globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, and boosting demand for CROs to conduct clinical trials. CROs diversified expertise as compared to pharmaceuticalcompanies with respect to performing clinical trials in wide array In January 2015, Hospira submitted one of the biosimilar versions of Epogen (Epoetin Alfa) and the result of the review in the U.S. is anticipated from the FDA within a year.

Related Industrys:Accenture, Cipla, Alkem, Allergan, Cognizant, Glenmark, GVK, Quantum Ltd, Pharma Arc, Lambda, Merck.

Societies and Associations:

International Society of PharmacovigilanceEuropean Society for Clinical InvestigationInternational Society of Pharmacovigilance,  Clinical Research SocietyJapan CRO AssociationAssociation of Clinical Research ProfessionalsAmerican Association of Pharmaceutical ScientistsPan-Asian Clinical Research AssociationThe Society of Clinical Research Associates

  • Emerging technology in clinical trials
  • Recent clinical trials on AIDS
  • Clinical trials on benign and malignant tumors
  • Clinical trials on cardiovascular diseases
  • Clinical trials on diabetes
  • Clinical trials of monoclonal and polyclonal antibodies
  • Clinical trials on drugs used in psychological disorders
  • Applications of biomarkers in clinical trials

Related Conference of Clinical Trials on Various Disorders

Clinical Trials on Various Disorders Conference Speakers